CLARIVATE PLC 8-K
Research Summary
AI-generated summary
Clarivate Plc Adopts Amended Executive Severance Plan
What Happened Clarivate Plc announced on March 23, 2026 that its Board, following the HR & Compensation Committee recommendation, adopted an Amended and Restated Executive Severance Plan (A&R Executive Severance Plan), updating the Original Executive Severance Plan adopted June 30, 2021. The A&R plan covers members of the company’s Executive Leadership Team (other than the Executive Chairman), named executive officers and other employees designated by the HRCC, and provides for severance payments and accelerated equity vesting on specified terminations (Qualifying Terminations).
Key Details
- Effective date: March 23, 2026; original plan adopted June 30, 2021.
- The CEO is now explicitly eligible under the A&R Executive Severance Plan (new from the Original ESP).
- For Qualifying Terminations not in connection with a change in control:
- Outstanding unvested service‑based RSUs granted prior to April 1, 2027 that would have vested over the 18 months after termination will vest in full.
- RSUs granted on or after April 1, 2027 will vest on a prorated basis.
- For Qualifying Terminations in connection with a change in control:
- All outstanding RSUs vest in full.
- Performance‑based unvested RSUs will vest as if performance metrics were met, at a level to be determined by the HRCC.
- The full text of the A&R Executive Severance Plan is filed as Exhibit 10.1 to the 8‑K.
Why It Matters These amendments expand which executives (including the CEO) are eligible for severance protections and accelerate equity vesting in certain termination scenarios, particularly in change‑in‑control situations. For investors, that means the company has increased the circumstances under which executives could receive severance payments or accelerated equity payouts; the filing does not disclose dollar amounts or specific participants’ payouts. Watch future filings (e.g., proxy statements or 8‑Ks) for any disclosure of actual severance costs, affected executives, or changes to compensation expense and potential dilution.
Loading document...